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Abstract The c~-Iml conotoxin, a selective potent inhibitor of 
the mammalian euronal c~7 nicotinic acetylcholine receptor (n- 
AcbR), was shown by point mutation or by L-alanine scanning to 
display two regions essential for bioactivity: the active site Asp s- 
Pro6-Arg 7 in the first loop and Trp l° in the second loop. The 
deletion of the Cys3,Cys 12 disulfide bond in the cc-ImI scaffold, 
e.g. peptide II, had no effect on its binding affinity. CD spectra, 
NMR studies and structure calculations were carried out on the 
wild type ~-Iml, the weakest analog (R7A) and peptide II 
(equipotent o ct-lmI) in order to point out the conformational 
differences between these compounds. Then, an attempt to 
correlate the conformational data and the affinity results was 
proposed. CD and NMR data were identical for the R7A analog 
and cc-ImI, revealing the crucial functional role of the Arg 7 side 
chain. On the other hand, the scaffold of the first loop in peptide 
lI was shown by NMR to represent the minimal conformation for 
the optimal interaction of the toxin with the neuronal c~7 n-AchR. 
Last, the [~-turn forming property of the 6th residue (Pro) in the 
active site of the ct-ImI can be correlated with its affinity. 
© 1999 Federation of European Biochemical Societies. 
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I. Introduction 
c~-Conotoxins, i olated from venomous marine cone snails, 
are small disulfide-rich peptides which block, like the ct-neuro- 
toxins from snake venoms, the nicotinic acetylcholine r ceptor 
(n-AChR) at the neuromuscular junction and lead to flaccid 
paralysis. The best characterized examples of c~-conotoxins 
are c~-GI and c~-MI conotoxins (for a review see [1]). Recently, 
new ct-conotoxins which do not interact with the muscular 
receptor but specifically with different neuronal n-AChR sub- 
types were discovered. The c~-ImI from Conus imperialis [2], c~- 
EpI from Conus episcopatus [3], ~x-MII from Conus magus [4], 
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Abbreviations: Fmoc, fluorenylmethyloxycarbonyl; n-AchR, nicotinic 
acetylcholine receptor; S-cam, S-carboxymethyl; S-acre, S-acetamido- 
methyl; Nle, L-norleucine; CD, circular dichroism; HEK, human em- 
bryonic kidney; i.c.v., intracerebroventricular injection; DQF-COSY, 
double quantum filtered correlation spectroscopy; NOESY, nuclear 
Overhauser nhancement spectroscopy; rmsd, root mean square de- 
viation; TOCSY, total correlation spectroscopy 
and c~-AuIB from Conus aulicus [5] are selective potent inhib- 
itors of mammalian euronal n-AChR of the c~7, the cGI32, 
the c~3134, the cd132 and the cz3134 subtypes, respectively (Fig. 
1). On the other hand, two c~-conotoxins from Conus penna- 
ceus (c~-PnIA and c~-PnIB) block specifically the neuronal 
AChR in mollusc [6]. 
c~-ImI was reported to have negligible ffects on the mam- 
malian neuromuscular transmission whereas after i.c.v, injec- 
tion in rat it causes complex seizures by high affinity blocking 
of the neuronal homomeric ~7 n-AchR [2,7,8]. Recently, c~- 
ImI mutants either by L-alanine scan [9] or point mutations 
[10] were synthesized and their binding affinity was measured. 
The results revealed two key regions in ~-ImI essential for 
bioactivity: the sequence Dsp6R 7 is a major determinant as- 
sisted by the W 1° residue [9,10]. Furthermore, the deletion of 
the disulfide bond (Cys3,Cys ~2) had no effect on the toxin 
affinity as reported for peptide II [9] in which Cys2,Cys 8
were bridged and Cys3,Cys 12 were acetamidomethylated 
(Fig. 1). On the other hand, the additional deletion of the 
(Cys2,Cys 8) disulfide bond caused a 17-fold affinity decrease 
for peptide I [9] in which CysZ,Cys 8were carboxamidomethyl- 
ated and Cys3,Cys 12 were acetamidomethylated (Fig. 1). 
Therefore, the first loop cZCSDPRC 8 is important for the 
binding affinity. This first loop was located in a distorted helix 
DSpRCAWR ll according to the 3D structure of the c~-ImI 
[11,12]. 
From previous binding results of c~-ImI [9,10] and the 3D 
structure of c~-ImI [11,12], a question arises about the confor- 
mation of cMmI after successive mutations of the active site 
residues in the first loop (Ds,p6,R7). The other question con- 
cerns the structural role of the Cys 2,Cys 8 disulfide bond in the 
binding affinity of the ct-ImI. To address these questions, we 
carried out CD measurements of the L-Ala series of ~-ImI 
analogs, various mutants in the active site (D5N, P6S, 
R7K), peptide I and peptide II. Simultaneously, a compara- 
tive NMR study of c~-ImI, monodisulfide (Cys2,Cys ) peptide 
II, and the R7A analog was conducted. Together, the com- 
parative CD and NMR methods enabled a possible correla- 
tion between the conformation of ~-ImI and its binding affin- 
ity and allowed the understanding of the structural role of 
each residue in the active site of c~-ImI and its selectivity for 
the c~7 n-AchR. 
2. Materials and methods 
2.1. Solid phase peptide synthesis 
Conotoxin c~-Iml and analogs were synthesized bysolid phase using 
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e-Conotoxins Sequence 
e- ImI  
~-EpI  
~-MII 
~-Pn IA  
~-Pn IB  








e-SI I  
GCCSDPRCAWR .. . .  C-NH 2 4/3 
GCCSDPRCNMNNPDYC-NH 2 4/7 
GCCSNPVCHLEHSNLC-NH 2 4/7 
GCCSLPPCAANNPDYC-NH 2 4/7 
GCCSLPPCALSNPDYC-NH 2 4/7 
GCCSYPPCFATNPD-C-NH 2 4/7 
ECCN-PACGRH--YSC-NH2 3/5 
ECCN-PACGRH--YSCGK-NH2 3/5 
GRCCH-PACGKN- -YSC-NH 2 3/5 
ICCN-PACGPK--YSC-NH2 3/5 
YCCH-PACGKNF--DC-NH2 3/5 
GCCCN-PACGPN- -YGCGTSCS 3/5 
Species Receptor Ref. 
target 
neuronal  
c. imperia i i s ~7 [2] 
C. episcopatus a3/~2;a3/~4 [3] 
C.magus ~3/~2 [4] 
c.pennaceus mollusc [6] 
C .pennaceus mollusc [6] 
C. aulicus a3/~4 [5] 
muscu lar  
C. geographus ~/6, Ct/y [1] 
C. geographus ~/6, c~/y [1] 
C.magus (I/~,O~/~ [1] 
C. seriatus ~/~,(~/~ [1] 
C. striatus C~/~/y [1] 
C. striatus (~/~(~/~ [1] 
Pept ide I 
GC (Scam) C (Sacm) SPDRC (Scam )AWRC (Sacm) -NH 2 
Pept ide I I 
I ] 
GCC (Sacm) SDPRCAWRC (Sacm) -NH 2 
Abbreviations:Scam,S-carboxamidomethyl;S-acm,S-acetamidomethyl; 
O = hydroxyprol ine.  
Fig. 1. c~-Conotoxin sequences, loop sizes, species of origin and n-AchR targets. 
the Fmoc chemistry. The details of synthesis and purification have 
already been reported [13]. The linear peptide Cys:,S(S-cam) 
Cys3'12(S-acm) or peptide I were prepared by reaction of an excess 
of iodoacetamide with the Cys2'S,Cys3I2(S-acm) peptide in 0.1 M Tris- 
HC1 buffer pH 8 and purified by HPLC. The overall yield of the c~- 
Iml conotoxin and analogs ranged from 10 to 11% calculated from 
the starting Fmoc-Rink-AM-amide r sin obtained from Novabiochem 
(Switzerland). Synt'hetic z-ImI and analogs were characterized by 
amino acid analysis, analytical HPLC and electrospray ionization 
mass spectrometry. 
2.2. a7 Neuronal homooligomer AChR expression m HEK cells 
The chimeric neuronal ot7-5HT3 receptor is expressed transiently in 
HEK cells as described previously [14]. The cDNA of the ~7-5HT3 
receptor was kindly provided by Prof. J.P. Changeux (Institut Pasteur, 
Paris). 
2.3. Binding assays 
The inhibition of 125I-bungarotoxin (12SI-Bgtx) binding to the c~7 
AChR by c~-Iml conotoxin was measured by competition experiments 
as described previously [14]. 
2.4. Circular dichroism measurements 
CD spectra were recorded on a Jobin Yvon CD6 dichrograph by 
accumulating 20 scans obtained with an integration time of 0.5 s every 
0.2 rim. Peptide concentration was in the range of 0.5 1.0 mg/ml of 
sodium phosphate buffer (50 raM) at pH 7. Due the low solubility of 
the Nle 7 analog in aqueous olvent, its CD spectrum was recorded in 
a mixture of acetonitrile and phosphate buffer (50/50). The pathlength 
of the quartz cell is 0.2 mm and the ellipticity is expressed in deg cm 2 
dmol 1. 
2.5. NMR spectroscopy 
Peptides were dissolved at 5 6 mM concentrations in 90% H20/10% 
D20, 0.1 M potassium phosphate buffer pH 5.8. The NMR spectra 
were recorded at 5°C on a Bruker Avarice DRX 500 spectrometer 
with a 5 mm (IH, 13C, 15N) triple resonance probe head, equipped 
with a self shielded z-gradient coil. DQF-COSY [15], TOCSY [16,17] 
and NOESY [18,19] experiments were recorded with 512 (tl)X 1024 
(t2) complex data points. The spectral width was 11.0 ppm in both 
dimensions. Data were processed using the GIFA V.4 software [20]. 
Chemical shifts were referenced relative to H20 at 5°C (4.964 ppm). 
The mixing time was 80 ms for the clean-TOCSY experiments [21] 
and 150 or 300 ms for NOESY experiments. Water suppression i  
TOCSY and NOESY experiments was performed by the WATER- 
GATE sequence using a 3-9-19 pulse sequence with z-gradients 
[22,23], while a low-power presaturation was used during the relaxa- 
tion delay of the DQF-COSY experiments. The quadrature detection 
in the tl dimension was achieved using the States-TPPI method [24]. 
Interproton distance constraints were derived from the cross-peak 
intensities of the NOESY spectrum recorded with a mixing time of 
150 ms, and were classified into four categories, trong, medium, weak 
and very weak, as previously described [25]. The intensities of the 
NOESY cross-peaks corresponding to the distances H5-6, H4-5 and 
H6-7 of tryptophan were used as references for the strong category. 
2.6. Structure calculations 
The proposed models of the three peptides c~-ImI, R7A analog and 
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peptide II were calculated using the program X-PLOR version 3.851 
[26] and were analyzed using the MOLMOL 2.4 program [27] as 
previously described [25]. The structures were generated using consec- 
utively the force fields parallhdg.pro and CHARMM22 of X-PLOR. A 
total of 84 (53 sequential (i, i+1), 20 medium-range (i, i+n, n < 5), six 
long-range (i, i+n, n > 4) and five intra-residue), 68 (46 sequential, 15 
medium-range, four long-range, and three intra-residue) and 81 (46 
sequential, 24 medium-range, seven long-range, and five intra-residue) 
structurally relevant distance restraints were used for the structure 
calculations of c~-ImI, R7A analog and peptide II, respectively. Dihe- 
dral angle restraints were also used to restrain five Z~ angles for the 
residues C3, D 5, R 7, C s and W 1° of c~-conotoxin ImI. Three ZI angles 
restrained residues C 3, D 5 and W 1° of the R7A analog and four ZI 
angles restrained residues C3, D 5, R 7 and R H of peptide II. No inter- 
residue NOEs were found for protons of thioacetamidomethyl groups 
of residues C 3 and C 12 of peptide II. These groups were modelled as 
thiomethyl groups. Modelling of peptide II in which the thioacetami- 
domethyl groups of residues C 3 and C 12 were modelled as two SH 
groups led to structures with the same scaffold as those described in 
this report (data not shown). 
3. Results and discussion 
As previously demonstrated by chemical site-directed muta- 
genesis experiments, three c ntral residues D5, P6, R7 are 
crucial in the interaction of c~-[mI with the c~7 n-AchR 
[9,10]. Thus, the mutat ions of these residues cause at least a 
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Fig. 2. CD spectra in the far UV region (180-250 nm) of the c~-ImI 
conotoxin and analogs in aqueous buffer solution (50 mM sodium 
phosphate, pH 7). a: CD spectra of four L-Ala analogs: D5A, 
P6A, R7A, W10A c~-ImI analogs and the w.t. a-ImI. The CD sig- 
nals of the W10A analog were amplified 5000 times for comparison. 
b: CD spectra of four L-Xxx analogs: D5N, P6S, R7K analogs and 
the w.t. cMmI. The R7Nle analog,spectra was recorded in acetoni- 
trile/buffer (1/1). c: CD spectra of peptide II and peptide ! and the 
w.t. c~-lmI. 
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Fig. 3. Stereoviews of the NMR structures of c~-ImI conotoxin and 
its derivatives (all heavy atoms) superimposed from residue Cys 2 to 
Cys 12, for minimum (N, Ccq C) atomic rmsds. A: wild type (30 
models); B, R7A analog (27 models); C, peptide II (32 models). In 
D, the three closest structures to the geometric average of A, B, 
and C are superimposed each together using a MOLMOL ribbon 
presentation. The side chain heavy atoms of cysteines, Arg 11 and 
Trp 1° are presented as thick lines, medium lines, and thin lines for 
the wild type c~-ImI, the R7A analog and the peptide II with Cys 3 
and Cys 12 alkylated, respectively (see text). Nt and Ct represent the 
N-termini and C-termini. 
two orders of magnitude decrease in affinity. The W10 residue 
contr ibuted more moderately to the binding activity as shown 
by the three- and six-fold affinity decrease observed respec- 
tively for the W10F and W10A analogs [9,10]. Conversely, the 
W10T analog have a 30-fold reduced affinity [10]. These ob- 
servations emphasized the necessary presence of an aromatic 
or hydrophobic side chain at the 10th posit ion in the second 
loop of c~-ImI. 
In order to attr ibute the affinity decrease observed for the 
mutat ion in the active site (DSp6R 7) and the W 1° residue of c~- 
ImI [9,10] to a modification of the recognition process rather 
than a general structural perturbation, CD of different ana- 
logs of the active site was carried out in comparison to that of 
the native c~-lml. The CD spectrum of c~-ImI at neutral pH 
displayed two negative bands ~t-~* between 200 and 210 nm 
and n-~* near 220 nm (Fig. 2a). The spectrum resembles that 
of the c~-helix [28] except that the band intensities and ratio 
are different. This CD feature is a class C (helix-like) CD 
spectrum [29] and indicates the presence of type I [3-turn as 
has been shown by study of model peptides [30]. The NMR-  
established structure of c~-ImI consists of the CzCSD 5 type I 
[3-turn followed by a distorted helix DsPRCAWR ll which is 
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Table 1 
Structural statistics for the structures ~ of a-conotoxins ImI, ImlR7A and pepII in H20, pH 5.8 at 5°C 
ct-ImI a-ImIR7A ct-pepli 
of the calculated structures " Cartesian coordinate rmsd (A) vs. the average coordinates of the (N, C a, C) backbone atoms 
Residues 1 12 0.78_+0.28 0.48+0.17 
Residues 2 8 0.30_+0.13 0.18_+0.06 
1.49 -+ 0.94 
0.49 _+ 0.33 
X-PLOR potential energies (kcal mo1-1) (average+ S.D.) calculated with the allhdg.pro force field 
FI'OI'AL 122.57 _+ 3.80 -119.88 + 3.00 -125 + 6.22 
FBOND 4.54 + 0.35 4.47 + 0.25 4.17 + 0.26 
FANGLE 21.62 + 1.94 20.43 + 1.38 20.33 + 2.11 
FIMPR 0.84 + 0.19 0.78 + 0.09 0.86 + 0.27 
FCOULOMBlC -- 180.29 + 5.15 -- 183.29 + 4.49 182.53 --+ 4.35 
FNOE 0.17 + 0.10 0.31 + 0.07 0.48 + 0.20 
FTOTAL: total energy; FBOND: bond length deviation energy; FA:qCLE: valence angle deviation energy; FIMpR: deviation energy for the im- 
proper angles used to maintain the planarity of certain groups of atoms; FCOULOMBIC: Coulombic energy contribution; FNOE: experimental 
NOE function calculated using a force constant of 50 kcal mol 1 .~-2; FcDin: experimental function corresponding to the violation of the di- 
hedral angle constraints. 
~Respectively 30, 27 and 32 structures for c~-conotoxins lmI, ImIR7A and peplI. 
composed by a half turn S4DPR 7 and R7CAW m type I [3-turn 
[11,12]. The whole sequence is folded by two disulfide bonds 
CysZ,Cys 8 and Cys3,Cys 12. Therefore, the overall conforma- 
tion in solution of c~-ImI deduced from CD data can be as- 
signed as a highly constrained and distorted helix [11,12]. 
The observed CD patterns for several analogs of c~-ImI, 
modified in the active site DsPR 7 did not reveal a great dis- 
order of the helix-like spectra for D5N, P6S, the R7K ana- 
logs, except for the increased Cotton effect of the R7NIe ana- 
log due probably to the solvent effect, i.e. acetonitrile (Fig. 
2b). In spite of the helix-like CD spectra of the P6S and P6A 
analogs (Fig. 2a,b), the structural role of Pro 6 in the loss of 
activity of these two analogs i obvious due to the substitution 
of the corner residue Pro 6 that contributed to decrease the 
high [3-turn propensity of the DSPRC s tetrapeptide [31]. In 
fact, the proline residue and two disulfide bonds force the 
c~-ImI backbone to form continuous turns in helicoidal motifs 
[11,12]. Therefore, the loss of affinity going from P6S to P6A 
analogs can be correlated with the structural aspect. The low- 
er the potential of turn forming at the 6th position of c~-ImI, 
the higher is the loss of affinity. Two striking CD features 
were observed for L-Ala analogs of c~-ImI. The CD spectrum 
of the R7A analog was superimposable on that of the c~-ImI 
(CD measurements were carried out with the same accuracy in 
two separate xperiments) (Fig. 2a). Therefore, the difference 
in binding affinity between the wild type and the R7A analog 
was only due to the side chain difference rather than structural 
modification. The conformation of these two molecules could 
be considered identical, and this was further confirmed by the 
NMR study. The second different CD pattern is displayed by 
the W10A analog. The two bands of the helix-like CD spec- 
trum disappeared while one negative band around 200505 
nm appeared and has three orders of magnitude smaller 
than that of c~-ImI. This observation can be related to (i) 
the deletion of the strong contribution of the aromatic 
Trp 1° residue to the Cotton effect at 220 nm [32], (ii) the 
probable loss of the capacity of H-bond forming for 
NH(AlaI°)/NH(Trp 1°) with the CO(Pro 6) [11,12]. Therefore, 
the CD spectrum of the WIOA analog can be considered a 
CD pattern of a [3-turn structure similar to that of the model 
cyclo (d-Ava-Gly-Pro-Ser(OBut)-Gly) peptide [33]. 
Peptide I and peptide II displayed CD spectra (~lin at 
around 200 205 rim) with a profile resembling that of the 
W10A analog (Fig. 2c). It might be hypothesized that peptides 
I and II contain a certain fraction of ]3-turn imposed by the 
sequence DsPRC s [31]. Peptide I is probably more flexible and 
is less active than peptide II. Peptide II could preserve, more 
easily than peptide I, the two (4 ~ 1) H-bonds characteristic of 
a ]3-turn, NH(AspS)-CO(Cys2), NH(CysS)-CO(Asp 5) detected 
in the 3D structure [11,12]. Thus, the first loop of peptide II 
can form the same helix-like conformation as in the native c~- 
ImI. The cluster of the side chains of the active site Dsp6R 7 
can point in the same direction as in the native ct-ImI. This 
comparison enabled the understanding of the conformational 
role of the first loop in c~-ImI for its affinity. This was further 
verified by NMR.  
The sequence-specific resonance assignments of the c~-ImI, 
the R7A analog and peptide II were easily obtained [34]. The 
resonance of the Cys 2 amide proton of c~-ImI and R7A analog 
is not observed probably due to an extensive chemical ex- 
change with the solvent. The respective Cys 2 amide proton 
resonances of these two molecules are, however, observed 
on the fingerprint regions of their NOESY spectra recorded 
at 5°C. The two Hc~ to H]3 connectivities of Cys 2 are well 
identified in the aliphatic regions of both TOCSY and 
NOESY spectra (data not shown). Efficient magnetization 
transfers are observed for all nine other observable spin sys- 
tems. The TOCSY spectra of the R7A analog is very similar 
to that of c~-Iml showing that the chemical shift difference is 
minimal. Protons of the side chain of Arg 11 are shifted to high 
field suggesting a contribution of the ring current anisotropy 
of Trp 1°. Hc~ chemical shifts of peptide II differ more impor- 
tantly particularly in C-terminal residues like Arg 11 and Cys 12. 
This could result from the opening of the second disulfide 
bridge and the thiol alkylation. The peptide II presents a 
greater chemical shift dispersion in the NH-(F2) dimension 
mainly for residues 3 5, 8 9 and 11-12. Finally, the presence 
of strong Hc~-to-H&8'(i+l) NOE between D s and p6 with no 
Hc~-Hc~(i+I) cross-peak in the NOESY spectra indicates a 
unique trans conformation for the Ds-P 6 peptide bond of c~- 
ImI, R7A analog and peptide II, in agreement with the results 
recently reported for the wild type c~-ImI [11,12]. 
Fig. 3 shows the structures calculated for the three studied 
compounds that conform to both the experimental and the 
force-field restraints, and have no individual and systematic 
NOE violation exceeding 0.1 A. The values of total potential 
energies of each structure lie around -120  kcal mol - l  as in- 
dicated in Table 1. The (¢, gt) dihedral angles of the 3D 
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structures of a-Iml resulting from our work superpose xactly 
with the two other NMR structures described recently [11,12]. 
However, the three models differ slightly by the well-defined 
Zt values of residues Asp 5 (-178 + 3) and Trp I° (61 + 5) com- 
pared to the highly mobile side chain described by Maslenni- 
kov et al. [11]. Other differences for Cys 3 (Z1 = -48 + 6), Arg 11 
(Zl =-52+25)  and Cys 12 (ZI : - -67 +46) are also observed 
and can result from the different refinement procedures 
used. The models of c~-ImI, R7A analog and peptide II 
present a great homogeneity of their backbone (N, Ca, C) 
atoms and adopt helicoidal motifs. This result confirms the 
Hcz's upfield trend clearly illustrated when calculating the sec- 
ondary Ha chemical shifts (data not shown). Models of R7A 
analog consists in a well-defined 3D structure composed of a 
310-helix involving residues Cys 2 to Ser 4 followed by a regular 
c~-helix (as detected by the MOLMOL program [27]) compris- 
ing residues Pro 6 to Ala 9. These secondary structures appear 
in 25 of the 28 models calculated and only three models 
present a lack of 310-helix in the first loop. As for c~-ImI, 
the edifice of the R7A analog is stabilized by multiple hydro- 
gen bonds, of either i, i+3 (CO(Glyl)-NH(Ser4), CO(Cys2)- 
NH(AspS), CO(AspS)-NH(CysS), CO(CysS)-NH(Arg 11) and 
CO(Ala9)-NH(Cys12)) or i, i+4 (CO(AspS)-NH(Ala9), CO- 
(Pro6)-NH(Trp 1°) and CO(CysS)-NH(Cys12). The R7A analog 
displays exactly the same combination of 0, N and ZI dihedral 
angles to that of c~-ImI (data not shown). These results agree 
with the CD measurements and confirm the crucial role of the 
Arg 7 side chain for the c~-ImI affinity [9,10]. Furthermore, it 
can be noticed that the side chain of residue Arg ~l lies parallel 
to the Trp l° aromatic ring, explaining the peculiar chemical 
shifts observed the Arg 11 side chain. Models of peptide II 
describe the same scaffold as those of c~-ImI with lower struc- 
tural order as shown from its atomic rmsd in Table 1. While 
the mean structure is still composed of an c~-helix comprising 
residues Pro 6 to Ala 9, this (*-helix appears only in 14 of the 32 
structures. Twelve other structures present an additional 310- 
helix comprising residues Cys 2 to Ser 4. Six other structures 
present either a longer c~-helix from residue Pro 6 to Arg 11, 
or only a 310-helix in the first loop or no well-defined sec- 
ondary structures at all. Models of peptide II are stabilized 
by the same hydrogen bonds described for c~-ImI and R7A 
analog except for the absence of i, i+2 (including a AspS-Arg 7 
salt bridge) and i, i+3 (CO(ArgV)-HN(side chain of Trp 1°) and 
CO(Alag)-HN(Cys ~2) hydrogen bonds. These results correlate 
with the loss of helical contribution at 222 nm measured on 
CD spectra. Finally, peptide II differs from the wild type c~- 
ImI and the R7A analog by the orientation of the tryptophan 
side chain. The tryptophan indole ring that faced Arg ll side 
chain in the native c~-ImI and R7A analog is rejected to the 
opposite face of the molecule as shown in Fig. 3. This corre- 
lates with the changes of the chemical shifts observed for the 
Arg rr side chain protons. Clearly, the different orientation of 
the W 1° indole ring in peptide II does not affect its binding 
affinity comparing to that of c~-ImI [9]. This observation could 
be explained by the decrease of the conformational entropy of 
peptide II on binding to the receptor. The good fit of the 
Dsp6R7 active site of peptide II on the c~7 n-AchR could 
counterbalance this decrease and enabled the reverse orienta- 
tion of the W L° indole ring in peptide II. The compared NMR 
structures confirm the structural importance of the Cys2,Cys a
disulfide bridge that blocks the conformation of the DsP6R 7 
sequence in the first loop of the c~-ImI conotoxin. The second 
loop of c~-ImI even opened by the Cys3,Cys 12 disulfide dele- 
tion did not affect the affinity of the toxin, e.g. peptide II. 
A question arises on the selective targets of the two c~-con- 
otoxins, c~-ImI [2] and c~-EpI [3]. The two toxins share the 
same N-terminal sequence G1CCSDPRC 8 in the first loop 
but display a different sequence and size for the second loop 
(Fig. 1). According to the recently resolved 3D structure of c~- 
ImI [11,12] and in c~-EpI [35], their first loop structures are 
identical. Therefore, the selectivity of these two conotoxins for 
various neuronal subtypes could be due to the nature of the 
side chains and the conformation of their second loop. The 
confirmation of this hypothesis will be supported by further 
binding studies of c~-EpI mutants in its second loop. More- 
over, given that c~-EpI targets the cG[32, c~3134 n-AchR sub- 
types in bovine chromaffin cells [5], a comparative binding 
study of (z-EpI and c~-ImI on pure recombinant c~7 n-AchR 
subtype will be relevant for their respective selectivity. 
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